All Stories

  1. An engineered construct of cFLIP provides insight into DED1 structure and interactions
  2. A guide to prepare and crystallize the N-terminal domain of NEMO
  3. The structure of a highly conserved picocyanobacterial protein reveals a Tudor domain with an RNA binding function
  4. The structure of the unbound IKK-binding domain of NEMO
  5. A pseudo-receiver domain in Atg32 is required for mitophagy
  6. Cysteine modifiers suggest an allosteric inhibitory site on the CAL PDZ domain
  7. Backbone and side chain resonance assignments for a structured domain within Atg32
  8. A small molecule ligand for AphB increases activity
  9. The Peach RGF/GLV Signalling Peptide pCTG134 Is Involved In A Regulatory Circuit That Sustains Auxin And Ethylene Actions
  10. Cholera toxins ToxR and ToxS interact and are affected by bile salts and pH.
  11. A new class of inhibitors of the AraC family virulence regulator Vibrio cholerae ToxT
  12. Identification and Characterization of the Interaction Site between cFLIPL and Calmodulin
  13. A novel caspase 8 selective small molecule potentiates TRAIL-induced cell death
  14. Small-molecule inhibitors of JC polyomavirus infection
  15. Phosphorylation of Ezrin-Radixin-Moesin-binding Phosphoprotein 50 (EBP50) by Akt Promotes Stability and Mitogenic Function of S-phase Kinase-associated Protein-2 (Skp2)
  16. Protein Engineering of the N-Terminus of NEMO: Structure Stabilization and Rescue of IKKβ Binding
  17. Small Molecule Inhibition of the Na+/H+ Exchange Regulatory Factor 1 and Parathyroid Hormone 1 Receptor Interaction
  18. Monitoring ATP hydrolysis and ATPase inhibitor screening using1H NMR
  19. Engineering a soluble parathyroid hormone GPCR mimetic
  20. Recombinant production of TEV cleaved human parathyroid hormone
  21. Structure of the extracellular domains of human andXenopusFn14: implications in the evolution of TWEAK and Fn14 interactions
  22. Reining in Polyoma Virus Associated Nephropathy: Design and Characterization of a Template Mimicking BK Viral Coat Protein Cellular Binding
  23. A Stabilizing Influence: CAL PDZ Inhibition Extends the Half-Life of ΔF508-CFTR
  24. A Stabilizing Influence: CAL PDZ Inhibition Extends the Half-Life of ΔF508-CFTR
  25. ChemInform Abstract: Parathyroid Hormone and Parathyroid Hormone-Related Protein: Model Systems for the Development of an Osteoporosis Therapy
  26. Pharmacological stabilization of ΔF508-CFTR at the cell surface: design of CAL-selective PDZ inhibitors
  27. Structure of Vibrio cholerae ToxT reveals a mechanism for fatty acid regulation of virulence genes
  28. Structural analysis of the human cannabinoid receptor one carboxyl‐terminus identifies two amphipathic helices
  29. Structure of a NEMO/IKK-Associating Domain Reveals Architecture of the Interaction Site
  30. Structural characterization of the parathyroid hormone receptor domains determinant for ligand binding
  31. N-Terminally PEGylated Human Interferon-β-1a with Improved Pharmacokinetic Properties and in Vivo Efficacy in a Melanoma Angiogenesis Model
  32. The Δe13 Isoform of the Calcitonin Receptor Forms a Six-Transmembrane Domain Receptor with Dominant-Negative Effects on Receptor Surface Expression and Signaling
  33. A 13C NMR approach to categorizing potential limitations of α,β-unsaturated carbonyl systems in drug-like molecules
  34. Receptor–Ligand Interactions
  35. Toward Parathyroid Hormone Minimization:  Conformational Studies of Cyclic PTH(1−14) Analogues
  36. NMR studies of CCK-8/CCK1complex support membrane-associated pathway for ligand-receptor interaction
  37. The PDZ1 Domain of SAP90: CHARACTERIZATION OF STRUCTURE AND BINDING
  38. Structural characterization of lipopeptide agonists for the bradykinin B2 receptor
  39. Molecular Characterization of the Substance P{middle dot}Neurokinin-1 Receptor Complex: DEVELOPMENT OF AN EXPERIMENTALLY BASED MODEL
  40. Photoaffinity Labeling of Mutant Neurokinin-1 Receptors Reveals Additional Structural Features of the Substance P/NK-1 Receptor Complex
  41. Structural characterization of lipopeptide agonists for the bradykinin B2 receptor
  42. CtrΔe13, a Calcitonin Receptor Isoform Lacking 14 Amino Acids in Transmembrane Helix 7: Structure and Topology
  43. Characterizing the Interactions Between Cholecystokinin and the G-Protein Coupled Receptors CCK1 and CCK2: An NMR-Based Study
  44. Probing the Importance of the N-Terminal Helix of Parathyroid Hormone: Introduction of Cyclohexylalanine to Tether to the Membrane
  45. Agonist Activity at the Kinin B1 Receptor:  Structural Requirements of the Central Tetrapeptide
  46. Structure-Based Optimization of Peptide Inhibitors of Mammalian Ribonucleotide Reductase,
  47. Molecular Complex of Cholecystokinin-8 and N-Terminus of the Cholecystokinin A Receptor by NMR Spectroscopy
  48. Expression and Spectroscopic Analysis of Soluble Nicotinic Acetylcholine Receptor Fragments Derived from the Extracellular Domain of the α-Subunit †
  49. Probing the Topological Arrangement of the N- and C-Terminal Residues of Bradykinin for Agonist Activity at the B1 Receptor
  50. Molecular Characterization of the Receptor−Ligand Complex for Parathyroid Hormone
  51. Structural characterization of peptide hormone/receptor interactions by NMR spectroscopy
  52. Structural characterization of peptide hormone/receptor interactions by NMR spectroscopy
  53. Motif Mutation of Bradykinin B2 Receptor Second Intracellular Loop and Proximal C Terminus Is Critical for Signal Transduction, Internalization, and Resensitization
  54. Parathyroid Hormone-Receptor Interactions Identified Directly by Photocross-linking and Molecular Modeling Studies
  55. Binding Domain of Human Parathyroid Hormone Receptor:  From Conformation to Function,
  56. 1,2,5-Trisubstituted 1,4-diazepine-3-one: A novel dipeptidomimetic molecular scaffold
  57. Conformational investigation of a novel dipeptide based molecular scaffold
  58. Addressing the Tertiary Structure of Human Parathyroid Hormone-(1-34)
  59. Structure, dynamics, and topological orientation of the polyether, ionophore antibiotic monensin, in a micellar environment
  60. Structure, dynamics, and topological orientation of the polyether, ionophore antibiotic monensin, in a micellar environment
  61. Conformational Studies of RS-66271, an Analog of Parathyroid Hormone-Related Protein with Pronounced Bone Anabolic Activity
  62. Conformational consequences of i, i + 3 cystine linkages: nucleation for α‐helicity?
  63. Synthesis of a Trisubstituted 1,4-Diazepin-3-one-Based Dipeptidomimetic as a Novel Molecular Scaffold
  64. A Trisubstituted 1,4-Diazepine-3-one-Based Dipeptidomimetic:  Conformational Characterization by NMR and Computer Simulation
  65. Threonine6-Bradykinin:  Molecular Dynamics Simulations in a Biphasic Membrane Mimetic
  66. Threonine6-Bradykinin:  Structural Characterization in the Presence of Micelles by Nuclear Magnetic Resonance and Distance Geometry
  67. Threonine6-bradykinin: Conformational study of a flexible peptide in dimethyl sulfoxide by NMR and ensemble calculations
  68. Peptide Mimetic of the Third Cytoplasmic Loop of the PTH/PTHrP Receptor
  69. Threonine6‐bradykinin: Conformational study of a flexible peptide in dimethyl sulfoxide by NMR and ensemble calculations
  70. Conformational characterization of a peptide mimetic of the third cytoplasmic loop of the G-protein coupled parathyroid hormone/parathyroid hormone related protein receptor
  71. Conformation of cyclobradykinin by nmr and distance geometry calculations
  72. Conformation of parathyroid hormone antagonists by CD, nmr, and molecular dynamics simulations
  73. RS-66271, a clinical candidate derived from parathyroid hormone related protein: The role of enhanced amphiphilic helicity
  74. Molecular characterization of the interaction between parathyroid hormone and its receptor
  75. Lactam cyclization [i to (i+4)] for nucleation/stabilization of α-helices?
  76. Identification and exploitation of structural foci that influence conformational mobility in somatostatin agonists and antagonists
  77. Secondary and tertiary fold of the human parathyroid hormone1–34 in different environments as a pathway to bioactive conformation